- About ASOPRS
- Membership
- Symposia
- Fellowships
- OPS Community
|
|
| Early Fees End 9/7/26 |
Late Fees 9/8/26 - 10/6/26 |
Onsite Fees 10/7/26 - 10/9/26 |
|
| Members & International Associates | $195 | $240 | $280 |
| Candidate Members & ASOPRS Fellows-in-Training | $390 | $460 | $530 |
| Life Members | $0 | $100 | $150 |
| Reciprocal Society Members* | $735 | $845 | $975 |
| Non-Member MDs | $1,035 | $1,240 | $1,430 |
| Medical Students, Residents, & Non-ASOPRS Fellows-in-Training | $390 | $460 | $530 |
| Allied Health/Office Staff | $535 | $640 | $740 |
| Industry (observers)** | $2,500 | $3,000 | $3,500 |
*Reciprocal Society Members - please email [email protected] for the discount code.
**Employees of industry/commercial interests must register to attend as observers-only using a separate form (available on this page in mid-July).
ASOPRS Reception (Thursday evening) tickets are $65.
SYMPOSIUM PROGRAM
Subject to change
THURSDAY, OCTOBER 8, 2026
7:30 am - 5 pm General Session, Breakouts, Lunch, Breaks
| Case Reports | ||
| 7:31 | Eyelid ecchymosis as a presenting sign of acute infectious purpura fulminans | Libing Kathy Dong |
| 7:34 | Coexisting Thyroid Eye Disease and IgG4-Related Ophthalmic Disease With Bilateral Superior Ophthalmic Vein–Associated Lesions: A Two-Patient Case Series | Tomoyuki Maeda |
| 7:37 | Primary Lacrimal Sac Melanoma: A Case Series | Alejandro Henao-Posada |
| 7:40 | Asymmetric Clinical Response in Bilateral Conjunctival Squamous Cell Carcinoma: Implications of Tumor Profiling | Joseph DeSimone |
| 7:43 | Pembrolizumab as first-line treatment for non-metastatic Merkel cell carcinoma of the eyelid | Arjun Yogaratnam |
| 7:46 | Novel treatment of a periorbital epithelioid hemangioma with sirolimus | Alexander Lieu |
| 7:49 | Intraorbital Chlorpromazine for Refractory Persistent Socket Pain Following Enucleation: A Case Report | Adam Neuhouser |
| 7:52 | A Rare Case Report of Orbital Nodular Fasciitis: Benign Imposter of the Orbit | April Lee |
| 7:55 | Off-Label Therapeutic Use of Intramuscular Nonavalent Human Papillomavirus Vaccine for Primary Conjunctival Squamous Cell Carcinoma with Orbital Involvement | Maya Harrington |
| Eyelid Oncology Session | ||
| 8:03 | Comprehensive In Silico Identification and Structural Modeling of Fusion Junction Neoantigens as Vaccine Targets in Adenoid Cystic Carcinoma | Tatiana Rosenblatt |
| 8:09 | Does GLP-1 Receptor Agonist Use Decrease Risk of Facial Cutaneous Malignancy? | Nishita Sheth |
| 8:15 | Advanced Conjunctival Squamous Cell Carcinoma that Failed Immunotherapy Treatment | Michael Kozlov |
| 8:21 | Incidence of Metastasis in Conjunctival Squamous Cell Carcinoma Requiring Orbital Exenteration: A Case Series | Javier Moreno Aleman |
| 8:27 | Limited Prognostic Value of Sentinel Lymph Node Biopsy in Periocular Malignant Melanoma Treated with Mohs Micrographic Surgery | Justus Zemberi |
| 8:33 | Questions and Discussion |
| TikTalks | ||
| 8:43 | Association of Floppy Eyelid Syndrome with Increased 10-Year Incidence of Depression and Anxiety | Grace Casado |
| 8:44 | Industry Payments for Three Oculoplastic-Relevant Drug Classes: An Eight-Year Analysis of CMS Open Payments | Henry Bair |
| Orbit Session | ||
| 8:46 | Validation of the Hawkeye Orbital Fracture Prioritization and Evaluation (HOPE) Algorithm for Orbital Fracture Triage | Josh Kettelkamp |
| 8:52 | Outcomes of Patients Undergoing Enucleation With and Without Postoperative Conformer Placement: A 12-Year Retrospective Chart Review | May Ameri |
| 8:58 | Optic Neuropexy With Interposition Fat Grafting to Facilitate Stereotactic Radiosurgery After Resection of Perioptic Tumors | Hyun Jun Kim |
| 9:04 | Reconstruction in transorbital skull base surgery: evolution of free fat graft volume and globe symmetry following lateral transorbital approaches to the middle cranial fossa | Melissa Li |
| 9:10 | Questions and Discussion |
| TikTalks | ||
| 9:20 | Rural Firearm-Related Ocular Injuries: Characterizing a High-Risk Population with Behavioral Disorders | Frida Velcani |
| 9:21 | Instagram vs. Reality: Quality and Consistency of Blepharoplasty Photos Posted by ASOPRS Surgeons | Kendall Goodyear |
| Practice Management | ||
| 9:23 | Declining Inflation-Adjusted Medicare Reimbursements in Oculofacial Surgery | Michael Kozlov |
| 9:29 | Cost Analysis of Outpatient Ophthalmic Plastic Surgical Procedures | Emily Moon |
| 9:35 | Prospective evaluation of sublingual anesthesia for oculoplastics procedures | Hailey Holck |
| 9:41 | Safety of Low-Level Disinfection for Reusable Instruments in Postoperative Eyelid Suture Removal: A Narrative Review and a Cost Savings Analysis of this Protocol | Tinea Morris |
| 9:47 | Ophthalmology Residents' Perceptions of Oculoplastics Fellowship: A National Survey | Taimur Siddiqui |
| 9:53 | Beyond the Chatbot: A 24/7 Agentic AI Assistant Across the Oculoplastic Surgeon's Workflow | Tonya Lee |
| 9:59 | Questions and Discussion |
10:09-10:39 am Break in Exhibit Hall
| Facial Aesthetics | ||
| 10:40 | Extended Endoscopic Brow Lift: A Comprehensive Technique for Upper Facial Rejuvenation | Remigio Flor |
| 10:46 | SMAS Flap Mobility in Deep-Plane Face Lifting | Sathyadeepak Ramesh |
| 10:52 | Skin-sparing Deep Plane Lower Eyelid Blepharoplasty and Midface Lift: Safety and Durability Outcomes of a Large Series of Patients in Brazil and California | Daniel Azzam |
| 10:58 | Is bony fixation really necessary in the endoscopic brow lift procedure? | Armin Avdic |
| 11:04 | QA |
| TikTalks | ||
| 11:16 | Impact of GLP-1 Receptor Agonist Use on Ptosis, Dermatochalasis, and Eyelid Surgery Risk Compared to Alternative Weight Loss Drugs: A Propensity Score-Matched Analysis | Ahmed Abdi |
| 11:17 | Who was the first of Oculoplastic Surgeon? | John Linberg |
11:18-11:51 am ASOPRS Baylis Cosmetic Award Lecture: John J. Martin, MD
12-1 pm Lunch, YASOPRS Round Tables, Product Theaters
| AI in Oculoplastics | ||
| 1:01 | Deep Learning for Detection of Orbital Pathology on MRI | Guy Ben Simon |
| 1:07 | Toward Oculoplastic Foundation Models: A Multi-Million Image External-Eye Dataset and Anatomical Evaluation Framework | George Nahass |
| 1:13 | Normative Volumes of Orbital Structures from AI-enabled CT Analysis | Zhenhan Lin |
| 1:19 | "Vibe coding" with AI to improve oculofacial practice efficiency | Brett Kotlus |
| 1:25 | Retrieval-Augmented Large Language Models Versus an Oculoplastic Surgeon for Perioperative Patient Questions: Accuracy, Safety, and Readability | Catherine Anderson-Quinones |
| 1:31 | Questions and Discussion |
| TikTalk | ||
| 1:41 | Lessons from an AI answering service | Frank Mei |
1:42-2:21 pm ASOPRS Foundation Lecture: Mary Beth Cunnane, MD,
Assistant Professor of Radiology at Harvard Medical School and Chief of Radiology at Mass Eye and Ear
| TikTalk | ||
| 2:21 | Hearing changes in patients with Thyroid disease and Thyroid Eye Diseases treated with Teprotumumab | Bhargavee Gnanasambandam |
| Orbit Session II | ||
| 2:23 | Ophthalmic Outcomes in Cavernous Sinus Thrombosis: Insights into Presentation, Etiology, and Management | Joseph DeSimone |
| 2:29 | Infectious versus Non-infectious Cavernous Sinus Thrombosis: Comparative Clinical Features, Management, and Ophthalmic Outcomes in 33 Patients | James Law |
| 2:35 | Risk Stratifying Pediatric Orbital Cellulitis Using Systemic Inflammatory Biomarkers | Evan Afshin |
| 2:41 | Multi-ancestry genome-wide association with fine-mapping identifies novel loci for nonspecific orbital inflammation | Patrick Demkowicz |
| 2:47 | Clinical and Histopathological Features of Ocular Adnexal Lymphoma Associated with Bone Erosion | Lynchel Brumaire |
| 2:53 | Questions and Discussion |
3:04-3:34 pm Break with Exhibitors
3:34-5 pm Breakouts in Aesthetics, Orbit, and Eyelid
5-6:30 pm ASOPRS Reception ticket required
FRIDAY, OCTOBER 9, 2026
7:30 am - 5 pm General Session, Breakouts, Lunch, Breaks
| Case Reports | ||
| 7:31 | Immune Checkpoint Inhibitor-Induced Myasthenia Gravis Presenting with Ophthalmic Manifestations Following Durvalumab for Muscle-Invasive Bladder Cancer | Katherine Lucarelli |
| 7:34 | A Novel Hypoglossal-Orbicularis Synkinesis | Imran Jivraj |
| 7:37 | The emergence of Corynebacterium bovis in lower blepharoplasty infections | Frank Mei |
| 7:40 | Corynebacterium Bovis Eyelid Abscess Following Blepharoplasty: A Rare Zoonotic Complication Linked to Manure Exposure | Nishita Sheth |
| 7:43 | Trabecular Architecture and Myxoid Stroma within an Orbital Plasma Cell Neoplasm | Rithvik Narendranath |
| 7:46 | Orbital Myxoid Pleomorphic Liposarcoma: A Newly Characterized Malignancy with Evolving Treatment Strategies | Caroline Cotton |
| 7:49 | Mucocutaneous Lesions Associated to the Use of Teprotumumab | Monica Manrique |
| 7:52 | Orbital melanoma arising within a cellular blue nevus: An atypical clinical presentation highlighting the role of immunohistochemical and molecular diagnostics | Kate Lim |
| 7:55 | Periorbital Mucinosis Successfully Managed with GLP-1 Agonist: A Case Report | Ryan Zukerman |
| Pediatrics | ||
| 8:03 | Periocular Disease Progression and Reconstructive Patterns in Parry-Romberg Syndrome | Vibhusha Kolli |
| 8:08 | Risk Factors Associated with Frontalis Sling Reoperation for Congenital Ptosis in the IRIS© Registry | Amee Azad |
| 8:13 | Surgical Management and Reoperation Rates in Pediatric Acute Dacryocystitis: A Multicenter Study | Marina Shenouda |
| 8:18 | A 15-year Single Center Review of Ptosis in Noonan Syndrome: Genotype-Specific Surgical Outcomes and Complication Patterns in a Pediatric Cohort | Zahra Markatia |
| 8:23 | Q+A |
| TikTalk | ||
| 8:28 | Smartphone-Based Facial Video Analysis for Monitoring Treatment Response After Botulinum Toxin Injection in Blepharospasm | Najung Kim |
| Eyelid II | ||
| 8:30 | Assessing Intraoperative Measurement Precision in Müller’s Muscle–Conjunctival Resection: A Histologic and Objective Analysis of Resected Tissue | Madeline Rosato |
| 8:36 | Frontalis Muscle Flaps for Severe Adult Ptosis or Apraxia of Eyelid Opening | Amee Azad |
| 8:42 | BlinkAssist: Development of a Discreet Wearable Device to Restore Blink Function | Helen Liu |
| 8:48 | Community-Acquired MRSA USA300 Periorbital Infections: Clinical Features, Risk Factors, and Outcomes in a Comparative Cohort Study | Annika Samuelson |
| 8:54 | Safety and Efficacy of DaxibotulinumtoxinA-lanm for Benign Essential Blepharospasm and Hemifacial Spasm | Audrey Yeung |
| 9:00 | Safety Profile of Local Tranexamic Acid Injection in Orbital and Oculofacial Surgery: A Large Retrospective Cohort Study of Adult and Pediatric Patients | Daniel Azzam |
| 9:06 | Questions and Discussion |
| TikTalk | ||
| 9:17 | Potential Benefit of Thyroidectomy in Aggressive Thyroid Eye Disease | Guy Ben Simon |
|
ASOPRS Thesis Presentations
|
||
| 9:19 |
Targeted Nanobody-E3 Ligase Degradation of PABPN1: A Novel Treatment Strategy for Oculopharyngeal Muscular Dystrophy
|
Marissa Shoji |
| 9:23 | Eyelid Malignancy in the Setting of Cosmetic Blepharopigmentation | Maja Magazin |
| 9:27 |
Localized Drug Delivery to the Nasolacrimal System Using a Shear-Thinning, Hyaluronic Acid-Based Hydrogel
|
Narmien Murdock |
| 9:31 |
Questions and Discussion, Award Presentations
|
9:34-10:04 am Break with Exhibitors
| Lacrimal & Oncology | ||
| 10:05 | Large population study identifies novel FOXA3 genetic variant and clinical associations in nasolacrimal duct obstruction | Michael Kryshtalskyj |
| 10:10 | Prior DCR as an Independent Predictor of Endoscopic DCR Failure: A 516-Patient Survival Analysis | Henry Bair |
| 10:15 | A Simplified Technique for Minor Salivary Gland Transplantation in Severe Aqueous-Deficient Dry Eye | Denise Kim |
| 10:20 | Autologous Minor Salivary Gland Transplant for Surgical Treatment of Severe Dry Eye Disease | Marissa Shoji |
| 10:25 | Questions and Discussion |
10:30-11 am Featured Speaker Dr. Greg Borschel
Professor and Chief of Plastic Surgery at Riley Hospital for Children at Indiana University Health
11 am - 12 pm ASOPRS Business Meeting
12-1 pm Lunch, Product Theaters, YASOPRS Lunch Event, Updates from Thyroid Eye Disease Clinical Trials (non-CME)
| Thyroid Session | ||
| 1:01 | Demographic Risk Factors for Thyroid Eye Disease in Pediatric Hyperthyroidism | Jawad Muayad |
| 1:07 | Extended 6-Week Teprotumumab Interval Reduces Audiometric Deterioration 2.6-fold compared to a Standard 3 Week Interval Schedule | Shoaib Ugradar |
| 1:13 | Predictors and Risk Stratification for Relapse After Teprotumumab for Thyroid Eye Disease | Helen Liu |
| 1:19 | Post-treatment Proptosis Reduction as a Predictor of Regression of Exophthalmos after Teprotumumab Treatment in Thyroid Eye Disease | Suzan Sargsyan |
| 1:25 | The molecular basis of proptosis reduction in thyroid eye disease patients after Teprotumumab therapy | Sarah Cheng |
| 1:31 | Retreatment Patterns in Thyroid Eye Disease After Relapse Following Teprotumumab | Helen Liu |
| 1:37 | Questions and Discussion |
| TikTalks | ||
| 1:52 | Cannabis Use and Vaping as Risk Factors for Thyroid Eye Disease | Carol Wann |
| 1:53 | What's in My Face?: Patient Knowledge of Cosmetic Injectables and the Patient-Safety Implications of Product-Identity Recall | Benjamin Meyer |
| Eyelid Aesthetics | ||
| 1:55 | Photorealism and Predictive Accuracy of an Identity-Preserving AI Simulation Platform for Blepharoplasty: A Blinded Multi-Rater Validation Study | Vlad Didorchuk |
| 2:01 | Externalized Suture Elimination in Microscope-Assisted Lower Blepharoplasty: A Comparative Cohort Study | Ryo Kikuchi |
| 2:07 | Long-Term Durability of Lower Eyelid Retraction Repair Following Hard Palate Graft Surgery: A 10-year Retrospective Single-Institutional Analysis | Evelyn Bassett |
| 2:13 | Radical Excision of Cicatricial Middle Lamella: A Spacer-Free Approach for Correcting Post-Cosmetic Lower Eyelid Retraction | Tomoyuki Kashima |
| 2:19 | Conservative Lateral Orbicularis Oculi Myomectomy for the Correction of Crow’s Feet Wrinkles | Adel Alsuhaibani |
| 2:25 | A New Protocol for Filler-Induced Blindness and Orbital Compromise Based on Systematic Analysis of Intra-Arterial Thrombolytic Treatment and International Consensus | Zhang-Nunes |
| 2:31 | Questions and Discussion |
| Get ASOPRS Famous Video Session | ||
| 2:42 | Pericranial Flap, Biodegradable Temporizing Matrix and Modified Fricke Cheek flap for Reconstruction of a Large Forehead, Brow and Upper Eyelid Defect. | Terry Henry |
| 2:45 | Management of Massive Recurrent Orbital Venolymphatic Malformation Following Sclerotherapy | ChaiTeck Choo |
| 2:48 | Lower Eyelid Re-tensioning Using Autologous Fascia Lata Sling: Surgical Technique | Guy Ben Simon |
| 2:51 | Subcutaneous Temporal Brow Lift Technique Avoiding Flap Tension and Over-Resection | Helena Lam |
| 2:54 | Oculofacial Application of Robot-Assisted Microsurgery | Alex Engelman |
| 2:57 | Juxta-canalicular Tarsoconjunctival Flap Repair of Medial Lower Eyelid Retraction and Lagophthalmos | Daniel Azzam |
| 3:00 | Questions and Discussion |
3:10-3:40 pm Break with Exhibitors
3:40-5 pm Breakouts in Academic Practice, Private Practice, and Solo Practice
5 pm Ajdourn
This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education through the American Society of Ophthalmic Plastic & Reconstructive Surgery. The American Society of Ophthalmic Plastic & Reconstructive Surgery is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The American Society of Ophthalmic Plastic and Reconstructive Surgery designates this live activity for a maximum of 14 (estimated) AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
ABSTRACT SUBMISSION
The deadline to submit abstracts was Wednesday, May 6 at noon central. Authors will receive notice of inclusion in the program in mid-July.
HOTEL & TRAVEL
Hyatt Regency New Orleans
Reserve a room at the Hyatt Regency New Orleans at the ASOPRS group rate of $355/night plus taxes and fees. Group rate will be available until September 8, 2026 or until sold out.
The ASOPRS room block is for Tuesday-Thursday nights. If you are staying Friday night and beyond, please make a reservation with ASOPRS for Tuesday-Thursday and a separate reservation for remaining nights. This helps ASOPRS meet our reservations commitment with the hotel.
